Annovis Bio, Inc.盘中异动早盘大幅下跌5.44%报17.03美元

自选股智能写手04-29

北京时间2024年04月29日21时37分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价大幅跳水5.44%。截至发稿，该股报17.03美元/股，成交量5.277万股，换手率0.48%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-2.79倍。机构评级方面，在所有5家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2431863054?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-29 21:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2431863054","market":"us","top_or_hot":-1,"title":"Annovis Bio, Inc.盘中异动 早盘大幅下跌5.44%报17.03美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月29日21时37分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价大幅跳水5.44%。截至发稿，该股报17.03美元/股，成交量5.277万股，换手率0.48%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-2.79倍。机构评级方面，在所有5家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio, Inc.盘中异动 早盘大幅下跌5.44%报17.03美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio, Inc.盘中异动 早盘大幅下跌5.44%报17.03美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-29 21:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月29日21时37分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价大幅跳水5.44%。截至发稿，该股报17.03美元/股，成交量5.277万股，换手率0.48%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-2.79倍。机构评级方面，在所有5家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b","article_id":"2431863054","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2431863054","pubTimestamp":1714397870,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月29日21时37分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.44%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","ANVS":"Annovis Bio, Inc."},"translate_title":"Annovis Bio, Inc. fell 5.44% to $17.03 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":1},"content_text":"北京时间2024年04月29日21时37分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价大幅跳水5.44%。截至发稿，该股报17.03美元/股，成交量5.277万股，换手率0.48%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-2.79倍。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Soleno Therapeutics, Inc.、Immunitybio, Inc.、Mesoblast Ltd涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为544.18%、24.41%、12.05%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024(To Pur Com)、Zyversa Therapeutics, Inc.、Soleno Therapeutics, Inc.，振幅分别为28.57%、17.43%、14.62%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该公司管线产品有：Buntanetap 用于治疗慢性神经退行性疾病 - 包括 AD 和 PD； ANVS405治疗急性神经退行性疾病； 以及用于高级 AD 的 ANVS301。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431863054"}

Annovis Bio, Inc.盘中异动 早盘大幅下跌5.44%报17.03美元

精彩评论

Annovis Bio, Inc.盘中异动早盘大幅下跌5.44%报17.03美元